CNC · Centene Corp · Financials
$68.03
-2.14 (-3.05%)
At close · Oct 26
Return incl. dividend (before tax)
Earnings today
Market Cap
$33.61B
Shares
494.00M
Volume · Oct 26
6.52M
Avg daily vol (3M)
4.62M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$194.78B
+19.4%
FY2025
Net Income
-$6.67B
-301.9%
FY2025
Gross Margin
7.3%
-3.2pp
FY2025
Operating Margin
-3.91%
-5.9pp
FY2025
Diluted EPS
-$13.53
-314.4%
FY2025
Operating Cash Flow
$5.09B
+3203.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $193.5B – $197.5B | $202.94B | $194.78B | $163.07B | $154BG | $144.55B | $125.98BG | $111.12BG | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | $10.86B | $8.11B | $5.21B | $4.45B | $4.1B | $3.36B | |
| — | — | — | — | — | — | — | — | — | — | $43.35B | $35.4B | $19.39B | $14.2B | $10.15B | $7.57B | $4.95B | $4.19B | $3.79B | — | |
| — | $2.76B | $2.67B | $2.73B | $3.56B | $7.03B | $4.89B | $3.3B | $2.47B | $2.39B | $1.85B | $1.86B | — | — | — | — | — | — | — | — | |
| — | $16.17B | $14.21B | $17.07B | $17.64B | $16.92B | $14.49B | $107.81Bd | $72.17Bd | $57.73Bd | $46.54Bd | $38.74Bd | — | — | — | — | — | — | — | — | |
| — | — | 7.3% | 10.47% | 11.45% | 11.7% | 11.5% | 97.03%d | 96.7%d | 96.03%d | 96.18%d | 95.41%d | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | $1.83B | $1.31B | $931M | $677M | $577.9M | $477.77M | $447.92M | $444.73M | |
| — | $13.02B | $12.9B | $12.4B | $12.56B | $11.59B | $9.6B | $9.38B | $6.53B | $6.04B | $4.45B | $3.67B | $1.8B | $1.3B | — | — | — | — | — | — | |
| — | $666M | $685M | $692M | $718M | $817M | $770M | $719M | $258M | $211M | $156M | $147M | $24M | $16M | $6M | $5M | $5.56M | $4.12M | — | — | |
| — | $1.25B | $1.28B | $1.24B | $1.29B | $1.43B | $1.34B | $1.26B | $643M | $495M | $361M | $278M | $111M | $89M | $67M | $66M | $58.33M | $52M | $44M | $35.41M | |
| — | $208.58B | $202.4B | $159.9B | $151.07B | $143.23B | $124.2B | $108.03B | $72.86B | $58.66B | $47.18B | $39.34B | $22.06B | $16.1B | $10.59B | $8B | $5.01B | $4.29B | $3.96B | $3.23B | |
| — | -$5.64B | -$7.62B | $3.18B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.2B | $1.26B | $705M | $464M | $277M | $108M | $203.8M | $157.07M | $138.14M | $131.56M | |
| — | — | -3.91% | 1.95% | 1.9% | 0.91% | 1.42% | 2.77% | 2.39% | 2.43% | 2.48% | 3.11% | 3.1% | 2.8% | 2.55% | 1.33% | 3.91% | 3.53% | 3.37% | 3.91% | |
| — | -$4.39B | -$6.35B | $4.42B | $4.22B | $2.75B | $3.12B | $4.34B | $2.42B | $1.95B | $1.56B | $1.54B | $816M | $553M | $344M | $174M | $262.13M | $209.07M | $182.14M | $166.98M | |
| — | $655M | $678M | $702M | $725M | $665M | $665M | $728M | $412M | $343M | $255M | $217M | $43M | $35M | $27M | $20M | $20.32M | $17.99M | $16.32M | $16.67M | |
| — | $1.01B | $895M | $1.08B | $668M | $644M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | $3M | $5M | $8M | $6M | — | — | — | — | — | — | |
| — | -$4.63B | -$6.73B | $4.26B | $3.6B | $1.96B | $1.81B | $2.77B | $1.78B | $1.37B | $1.13B | $1.16B | $697M | $457M | $269M | $123M | $188.35M | $154.28M | $137.51M | $136.62M | |
| — | $474M | -$51M | $963M | $899M | $760M | $477M | $979M | $473M | $474M | $326M | $599M | $339M | $196M | $107M | $47M | $70.69M | $59.9M | $48.84M | $52.44M | |
| — | -$5.1B | -$6.67B | $3.31B | $2.7B | $1.2B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | $165M | $2M | $111.22M | $94.84M | $83.67M | $83.5M | |
| — | — | -3.43% | 2.03% | 1.75% | 0.83% | 1.07% | 1.63% | 1.77% | 1.5% | 1.71% | 1.38% | 1.56% | 1.64% | 1.52% | 0.02% | 2.13% | 2.13% | 2.04% | 2.48% | |
| — | -$6M | -$3M | -$11M | -$3M | $0 | -$11M | -$14M | -$12M | -$6M | -$20M | -$1M | $2M | -$7M | $1M | -$13M | -$2.86M | $3.44M | $2.57M | $0 | |
| — | -$5.06B | -$6.23B | $3.45B | $3.18B | -$7M | $1.09B | $2.01B | $1.51B | $847M | $861M | $536M | $346M | $273M | $157M | $1M | $110.56M | $93.91M | $85.29M | $85.08M | |
| USD/shares | — | -$10.32 | -$13.53 | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 | $3.19 | $2.31 | $2.40 | $1.76 | $2.98 | $2.33 | $1.52 | $0.02 | $2.22 | $1.95 | $1.94 | $1.93 |
| USD/shares | at least $4.80* | -$10.35 | -$13.53G | $6.31G | $4.95G | $2.07G | $2.28G | $3.12G | $3.14 | $2.26 | $2.34 | $1.71 | $2.88 | $2.25 | $1.47 | $0.02 | $2.12 | $1.88 | $1.89 | $1.88 |
| shares | — | — | 493.12M | 521.79M | 543.32M | 575.19M | 582.83M | 570.72M | 413.49M | 390.25M | 344.85M | 319.14M | 119.1M | 116.35M | 108.25M | 103.02M | 50.2M | 48.75M | 43.03M | 43.28M |
| shares | — | — | 493.12M | 523.74M | 545.7M | 582.04M | 590.52M | 579.14M | 420.41M | 398.51M | 353.4M | 327.95M | 123.07M | 120.36M | 112.49M | 107.43M | 52.47M | 50.45M | 44.32M | 44.4M |
d Gross profit for periods the company did not report it, or tagged its operating income as gross profit, is Revenue − Cost of Revenue. Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $9.68B in buybacks.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Latest reported total
USD 17,400,000,000
As of Dec 31, 2025
Tracked instruments
0
Loans, facilities and note series
Annual baseline
Dec 31, 2025
Latest approved annual total
Reported total debt history
| As of | Reported label | Amount | Source |
|---|---|---|---|
| 2025-12-31 | consolidated indebtedness | USD 17,400,000,000 |
10-K filed 2026-02-17
As of December 31, 2025, we had consolidated indebtedness of $17.4 billion. We may further increase or refinance our indebtedness in the future. |
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Debt and lease obligations | 2026-06-30 | USD 16,105,000,000 | 10-Q filed 2026-07-28 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.11×
Peer median 0.40×
EV/EBIT
—
Peer median 17.98×
P/E (TTM)
—
Peer median 21.37×
Peer medians compare against the 6 similar-size Healthcare Plans companies (of 13 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| All Other Segments | $16,854,000,000 | $16,879,000,000 | $16,735,000,000 | $25,191,000,000 | $23,654,000,000 | — | — | — |
| Commercial Segment | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Medicaid Segment | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Medicare Segment | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Managed Care | — | — | — | $135,055,000,000 | $120,119,000,000 | $106,862,000,000 | $71,209,000,000 | $56,999,000,000 |
| Specialty Services | — | — | — | $9,492,000,000 | $5,863,000,000 | $4,253,000,000 | $3,430,000,000 | $3,117,000,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Health Care Premium | $171,556,000,000 | $142,303,000,000 | $135,636,000,000 | $127,131,000,000 | $112,319,000,000 | $100,055,000,000 | $67,439,000,000 | $53,629,000,000 |
| Service | $3,025,000,000 | $3,202,000,000 | $4,459,000,000 | $8,348,000,000 | $5,664,000,000 | $3,745,000,000 | $2,925,000,000 | $2,806,000,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Managed Care | $1,913,000,000 | $1,789,000,000 | $3,031,000,000 | $1,806,000,000 | $1,310,000,000 | $917,000,000 |
| Specialty Services | -$595,000,000 | -$5,000,000 | $51,000,000 | -$25,000,000 | $148,000,000 | $282,000,000 |
Operating Margin by Segment (%)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Managed Care | 1.4% | 1.5% | 2.8% | 2.5% | 2.3% |
| Specialty Services | -6.3% | -0.1% | 1.2% | -0.7% | 4.7% |
Key facts
CIK
1071739
CUSIP
15135B101
13F (30d)
275 filings
261 filers
Visit website
Investor relations